𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Does a placebo-effect exist in clinical trials on multiple sclerosis? Review of the literature

✍ Scribed by L. La Mantia; M. Eoli; A. Salmaggi; C. Milanese

Publisher
Springer Milan
Year
1996
Tongue
English
Weight
450 KB
Volume
17
Category
Article
ISSN
1590-1874

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Does elimination of placebo responders i
Does elimination of placebo responders in a placebo run-in increase the treatment effect in randomized clinical trials? A meta-analytic evaluation
✍ Sandra Lee; John R. Walker; Laura Jakul; Kathryn Sexton πŸ“‚ Article πŸ“… 2004 πŸ› John Wiley and Sons 🌐 English βš– 109 KB

The use of a placebo run-in phase, in which placebo responders are withdrawn from a study before random assignment to treatment condition, has been criticized as favoring the active treatment in clinical trials. We compared the effect size of randomized, placebo-controlled clinical trials (in the tr

A phase II clinical trial does not show
A phase II clinical trial does not show that high dose simvastatin has beneficial effect on markers of bone turnover in multiple myeloma
✍ TE Sondergaard; PT Pedersen; TL Andersen; K SΓΈe; T Lund; B Østergaard; P Garnero πŸ“‚ Article πŸ“… 2009 πŸ› John Wiley and Sons 🌐 English βš– 176 KB

## Abstract Several studies have evaluated the impact of low dose statin (20–80 mg/day) on bone metabolism with inconclusive results despite promising data of preclinical studies. In this study, we investigated the effect of high dose simvastatin (HD‐Sim) on biochemical markers of bone turnover and